期刊文献+

沙丁胺醇与沐舒坦联合氧气驱动雾化吸入治疗老年肺炎预后探讨 被引量:1

Discussion on the Prognosis of Senile Pneumonia Treated by Salbutamol Combined with Mucosolvin and Oxygen-driven Aerosol Inhalation
下载PDF
导出
摘要 目的分析探讨沙丁胺醇与沐舒坦联合氧气驱动雾化吸入对于治疗老年肺炎的预后。方法随机选取2010年5月—2013年5月在该院进行治疗的46例肺炎老年患者,平均分为治疗组和对照组,各23例。两组患者均给予抗生素等常规治疗,治疗组患者加用沙丁胺醇与沐舒坦联合氧气驱动雾化吸入治疗,对比分析两组患者的疗效和预后。结果治疗组患者显效率为60.87%,总有效率95.65%。而对照组中显效率30.43%,总有效率86.96%,两组的总有效率差异无统计学意义(P>0.05),但治疗组的显效率显著高于对照组(P<0.05)。而两组患者治疗后咳喘消失、肺部啰音消失及住院时间差异有统计学意义,对照组患者明显长于对照组。结论沙丁胺醇和沐舒坦联合氧气驱动雾化吸入治疗老年肺炎疗效和预后均较好,值得临床推广应用。 Objective To analyze and discuss the prognosis of senile pneumonia treated by salbutamol combined with mucosolvin and oxygen-driven aerosol inhalation. Methods 46 cases of patients with senile pneumonia admitted in our hospital from May, 2010 to May, 2013 were randomly selected and divided into the treatment group and the control group with 23 cases in each. Two groups of patients were given antibiotics and other conventional treatment. In addition, the treatment group was given salbutamol combined with mucosolvin and oxygen-driven aerosol inhalation. The efficacy and prognosis were compared between the two groups. Results The significant efficiency of the treatment group was 60.87%, the total effective rate was 95.65%, while that of the control group separately was 30.43% and 86.96%, there was no statistically significant difference between the groups in total effec- tive rate (/)〉0.05), but the significant efficiency of the treatment group was obviously higher than of the control group (P〈0.05). The cough and pulmonary rales disappearing time after the treatment and the length of hospital stay of the control group were obvi- ously longer than those of the treatment group, the differences were significant. Conclusion Salbutamol combined with mucosolvin and oxygen-driven aerosol inhalation is quite effective in the treatment of senile pneumonia and the prognosis of the patients is good, which is worthy of clinical application.
作者 赵玉娟
出处 《中外医疗》 2014年第5期32-33,共2页 China & Foreign Medical Treatment
关键词 沙丁胺醇联合沐舒坦 雾化吸入 老年肺炎 预后 Salbutamol combined with mucosolvin Aerosol inhalation Senile pneumonia Prognosis
  • 相关文献

参考文献5

二级参考文献34

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:787
  • 3Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 4de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 5Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 6Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 7Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 8Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
  • 9Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433.
  • 10Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250.

共引文献3081

同被引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部